Clinical Trial Update: Safety and Efficacy of Umbilical Cord-derived Mesenchymal Stem Cell(MSC) Transplantation in the Treatment of Bronchopulmonary Dysplasia(BPD) in Premature Infants [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the safety and efficacy of transplanting umbilical cord-derived mesenchymal stem cells to treat bronchopulmonary dysplasia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Drugs mentioned

• Umbilical Cord-derived Mesenchymal Stem Cell Transplantation (umbilical cord-derived mesenchymal stem cells)

Snippet

Sponsor: The Children's Hospital of Zhejiang University School of Medicine | Conditions: BPD - Bronchopulmonary Dysplasia | Phase 1, Phase 2 | Status: RECRUITING